Skip to content

GMAB

Genmab A/S

NASDAQ · Healthcare · Biotechnology · DK

$34.74
+0.59%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
26.37x
P/E 2026E
29.28x
P/E 2027E
20.19x
P/E 2028E
13.33x
P/S forward
4.46x

Trailing multiples

Trailing twelve months

P/E TTM
27.20x
PEG TTM
8.63x
Price / book
3.59x
Price / sales
5.17x
Price / cash flow
23.99x

Enterprise value

Enterprise value
$25.1B
EV / sales
6.08x
EV / EBITDA
20.61x
EV / EBIT
18.84x
Market cap
$21.4B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026